SCHEMBL3945944

SCHEMBL3945944

CN1CCN(c2ccc(CNC(=O)c3n[nH]cc3-c3ccccc3)cc2)CC1.O=C(O)c1n[nH]cc1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.50
FLT3 P36888 4/20 0.48
KDR P35968 3/20 0.48
FLT1 P17948 2/20 0.48
KMT2A Q03164 1/20 0.48
AURKA O14965 3/20 0.47
SIRT6 Q8N6T7 1/20 0.46
MAPK14 Q16539 1/20 0.45
KDM1A O60341 1/20 0.44
HDAC1 Q13547 1/20 0.44
GFER P55789 1/20 0.44
PRKAB2 O43741 1/20 0.43
PRKAG1 P54619 1/20 0.43
PRKAA2 P54646 1/20 0.43
PRKAA1 Q13131 1/20 0.43
PRKAG3 Q9UGI9 1/20 0.43
PRKAG2 Q9UGJ0 1/20 0.43
PRKAB1 Q9Y478 1/20 0.43
HTR6 P50406 1/20 0.43
CLK1 P49759 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL953774 0.97 ACE2 (0.53) ACE2FLT3KDRFLT1KMT2A
SCHEMBL4441493 0.92 EGFR (0.49) ACE2FLT3KDRFLT1KMT2A
SCHEMBL955617 0.87 ACE2 (0.48) ACE2FLT3KDRFLT1KMT2A
SCHEMBL954427 0.85 MAPT (0.55) ACE2FLT3KDRFLT1KMT2A
SCHEMBL3945941 0.85 ACE2 (0.44) ACE2FLT3KDRFLT1KMT2A
SCHEMBL3941658 0.83 KMT2A (0.41) ACE2FLT3KDRFLT1KMT2A
SCHEMBL955230 0.79 ACE2 (0.48) ACE2FLT3KDRFLT1KMT2A
SCHEMBL3941655 0.76 KDR (0.42) ACE2FLT3KDRFLT1KMT2A
SCHEMBL8225257 0.75 ACE2 (0.50) ACE2FLT3KDRFLT1KMT2A
SCHEMBL28986003 0.73 HDAC3 (0.48) FLT3KDRFLT1KMT2AAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046330-A2 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-04-15 EP disclosed
EP-2046327-A1 MEDICAL USE OF CYCLIN DEPENDENT KINASES INHIBITORS Astex Therapeutics Limited (GB) 2009-04-15 EP disclosed
WO-2008009954-A1 MEDICAL USE OF CYCLIN DEPENDENT KINASES INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2008-01-24 WO disclosed
WO-2008007122-A2 COMBINATIONS OF PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDKS AND GSK'S ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 WO disclosed